Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$4.29 - $6.64 $74,482 - $115,283
-17,362 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$5.77 - $7.96 $100,178 - $138,201
17,362 New
17,362 $109,000
Q4 2020

Feb 16, 2021

SELL
$3.5 - $7.98 $223,300 - $509,124
-63,800 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$4.78 - $16.97 $304,964 - $1.08 Million
63,800 New
63,800 $424,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $93.6M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.